Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Yanaprima Hastapersada Tbk (YPAS) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Yanaprima Hastapersada TbkTrade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Yanaprima Hastapersada Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp228 (market cap 319B, 124.3K 24h volume), while Yanaprima Hastapersada Tbk trades at Rp1,200 (market cap 641.28B, 1.57M 24h volume). The key difference: Yanaprima Hastapersada Tbk is far larger — about 2× Diagnos Laboratorium Utama Tbk.'s market cap, and Yanaprima Hastapersada Tbk is more actively traded (1.57M versus 124.3K). Which is the better fit depends on your goals.

DGNSYPAS
Market Cap
319B641.28B
Volume
124.3K1.57M
Lot
1.24K15.65K
Turnover
28.28M1.87B
Average Price
227.481,195.67
Value
28.28M1.87B
Indicative Equilibrium Price
2281,200
Indicative Equilibrium Volume
100239

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
YPAS
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Yanaprima Hastapersada Tbk

PT Yanaprima Hastapersada Tbk (the Company) was established in Indonesia based on Notarial Deed No. 38 of Emmy Hartati Yunizar, S.H., dated December 14, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 5 of Marina Soewana, S.H., dated Nov 1, 2007, concerning among others, the change of capital stucture, Company name and public offering.

Read more on YPAS